These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4838230)

  • 1. Drug identification by imprint.
    Robertson KA; Robertson WO
    Clin Toxicol; 1974; 7(1):83-9. PubMed ID: 4838230
    [No Abstract]   [Full Text] [Related]  

  • 2. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 3. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 4. Prescription drug products; patient labeling requirements: proposed rule.
    Fed Regist; 1979 Jul; 44(131 Pt 2):40015-41. PubMed ID: 10242793
    [No Abstract]   [Full Text] [Related]  

  • 5. The patient package insert and its legal implications.
    Cook D
    Leg Med Q; 1980; 4():258-70. PubMed ID: 10258797
    [No Abstract]   [Full Text] [Related]  

  • 6. Package inserts, adverse drug reactions, and the physician's liability.
    Morrell MX
    Ration Drug Ther; 1975 Aug; 9(8):1-6. PubMed ID: 1144773
    [No Abstract]   [Full Text] [Related]  

  • 7. PDA response. FDA advance notice of proposed rulemaking on electronic identification/signatures. Parenteral Drug Association.
    J Parenter Sci Technol; 1993; 47(1):4-8. PubMed ID: 8445499
    [No Abstract]   [Full Text] [Related]  

  • 8. Wyeth preemption case ruling sparks labeling confusion.
    Allison M
    Nat Biotechnol; 2009 May; 27(5):399-400. PubMed ID: 19430423
    [No Abstract]   [Full Text] [Related]  

  • 9. Who's in charge here? OSHA's/OMB's labeling standard.
    Schechter D
    Occup Health Saf; 1982 May; 51(5):21-5. PubMed ID: 7078916
    [No Abstract]   [Full Text] [Related]  

  • 10. Some issues related to patient package inserts.
    Fink JL
    Hosp Formul; 1979 Feb; 14(2):181-3. PubMed ID: 10240143
    [No Abstract]   [Full Text] [Related]  

  • 11. The patient package insert--health care provider's friend or foe?
    Hirsh HL
    Nurs Homes; 1979; 28(4):24-5. PubMed ID: 10283734
    [No Abstract]   [Full Text] [Related]  

  • 12. The Food and Drug Administration's regulation of drug labeling, advertising, and promotion: looking back and looking ahead.
    Hayes TA
    Clin Pharmacol Ther; 1998 Jun; 63(6):607-16. PubMed ID: 9663174
    [No Abstract]   [Full Text] [Related]  

  • 13. All may not be meeting the eye.
    Archambault GF
    Hosp Formul; 1975 Aug; 10(8):414. PubMed ID: 10237848
    [No Abstract]   [Full Text] [Related]  

  • 14. Extra-label drug use--pharmaceutical industry view.
    Welser JR
    J Am Vet Med Assoc; 1993 May; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571
    [No Abstract]   [Full Text] [Related]  

  • 15. Labeling and record keeping for compounded drugs.
    Ballitch EJ
    J Am Vet Med Assoc; 1994 Jul; 205(2):249-50. PubMed ID: 7928591
    [No Abstract]   [Full Text] [Related]  

  • 16. Labeling regulations: 'prescribe as directed'.
    Regier H
    J Leg Med (N Y); 1974; 2(5):48-51. PubMed ID: 4548706
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 18. Plugs for drugs.
    Masson A; Rubin PH
    Regulation; 1986; 10(1):37-43, 53. PubMed ID: 10280556
    [No Abstract]   [Full Text] [Related]  

  • 19. An overview of current programs on drug development and regulation for small ruminants--pharmaceutical industry perspective.
    Terry M
    Vet Hum Toxicol; 1993; 35 Suppl 2():12-3. PubMed ID: 8236759
    [No Abstract]   [Full Text] [Related]  

  • 20. Relative efficacy. When the government decides what drugs should be prescribed, is the patient better served?
    Ohio State Med J; 1972 Aug; 68(8):748-52 passim. PubMed ID: 5077306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.